Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
In pancreatic cancer, the epigenomic landscape can strongly impact the disease phenotype. Here, the authors discuss recent advances in our understanding of pancreatic cancer epigenomics, and how this knowledge can integrate with precision medicine approaches in this lethal disease.
Enregistré dans:
Auteurs principaux: | Gwen Lomberk, Nelson Dusetti, Juan Iovanna, Raul Urrutia |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0784c10024e34076bcbf2a0a39e6dc2f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
par: Gwen Lomberk, et autres
Publié: (2018) -
Collateral Victim or Rescue Worker?—The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer
par: Lishu He, et autres
Publié: (2021) -
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
par: Federica Vernuccio, et autres
Publié: (2021) -
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
par: Feng Liu, et autres
Publié: (2017) -
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
par: Zi‐Hang Chen, et autres
Publié: (2021)